Gut mucosal microbes evolved closest to the host, developing specialized local communities. There is, however, insufficient knowledge of these communities as most studies have employed sequencing technologies to investigate faecal microbiota. This work used shotgun metagenomics of mucosal biopsies to explore the microbial communities compositions of terminal ileum and large intestine in 5 healthy individuals. Functional annotations and genome-scale metabolic modelling of selected species were then employed to identify local functional enrichments. While faecal metagenomics provided a good approximation of the average gut microbiome composition, mucosal biopsies allowed detecting the subtle variations of local microbial communities. Given their significant enrichment in the mucosal microbiota, we highlight the roles of Bacteroides species and describe the antimicrobial resistance biogeography along the intestine. We also detail which species, at which locations, are involved with the tryptophan/indole pathway, whose malfunctioning has been linked to pathologies including inflammatory bowel disease. Our study thus provides invaluable resources for investigating mechanisms connecting gut microbiota and host pathophysiology.
is colonised by a unique microbial community, including species such as Bacteroides fragilis and Akkermansia muciniphila 11, 12 . The importance of A. muciniphila is only starting to emerge in connection with several diseases: it is most beneficial to the host, although an excess has been linked to pathologies such as multiple sclerosis 13 and Parkinson's disease 14 . B. fragilis has been mostly studied because of its pathogenicity 15, 16 , although it has also been found to provide beneficial effects 17, 18 . Having evolved in closer proximity with the host than any other microbe, they affect the host's health in several ways that still lack a proper understanding. It is therefore of great interest to further investigate them in their own niche 5, 19 .
The majority of gut microbiome studies have employed faecal sampling for microbiota screening. In order to investigate the gut mucosa microbiota, mucosal biopsies, differently from stool samples, would allow the collection of specific microbial communities. The only studies available on colonic mucosal biopsies have employed 16S ribosomal DNA amplicon sequencing 2, 10, [20] [21] [22] or RNA sequencing 23 , which do not allow a reliable high throughput measurement of the microbial communities 24 .
In this study, we employed shotgun metagenomic sequencing, and a set of functional analysis methods, to investigate the microbiome along the large intestinal mucosa in a healthy subjects' cohort.
The main aim was to investigate if and how this technology can contribute to our understanding of the mucosal microbiota composition and function. We found that, while faecal samples provide a good approximation of the average gut mucosa microbiota, only biopsies could detail subtle but important compositional variations along the intestine. Signature species were identified at each biopsy location, and found, through functional analyses, to affect specific pathways which are known to affect certain physio/pathologic processes.
Results
To investigate the microbial biodiversity along the large intestine mucosa, we collected faeces samples and, after bowel cleansing, mucosal biopsies, from 5 healthy Swedish adults chosen from a previously published study 25 . Biopsies were taken from 3 locations: terminal ileum (TI), transverse colon (TC), and rectum (RE). As TI was not accessible for subject P1 (Supplementary Table 3 ), one of her biopsies was taken from caecum (CA) instead ( Figure 1A ). All samples were prepared for shotgun metagenomics sequencing. We generated, on average, 5.9 million paired-end reads per sample.
Whereas faecal samples yielded an average of 5.8 million unique read-counts mapping to the integrated reference catalogue of the human gut microbiome database, only an average of 0.15 million unique read-counts mapped to microbial genes in the biopsy-derived samples. This was due to the majority of reads, in biopsy-derived samples, mapping to human genes (97%). These data were thus used to generate two separately normalised gene-count tables and, correspondingly, MGSs abundance profiles ( Supplementary Table 4 ): one for faeces and one for biopsies. In the next sections, we detail how these datasets were used to investigate the microbial compositions of the biopsies and faeces samples ( Supplementary Figure 1) .
Individual microbial uniqueness is stronger than local mucosal microbiota variability. To evaluate the microbial biodiversity in our samples, we first computed their gene-and MGS-richness 26 . We downsized biopsy and faeces datasets together in order to take into account the different sequencing depths across samples ( Supplementary Figure 2 ). In the average, biopsies showed an 82,876 gene-richness, and a 23 MGS-richness. Both these values were about one order of magnitude lower than the corresponding ones for faecal samples (1,093,261 and 259, respectively) ( Supplementary Figure 3 ). Both gene-and MGS-richness showed no significant difference among biopsy locations.
We next looked at how subject-and sampling-location factors contributed to the microbiome diversity. The PCoA plot of the faeces-biopsies dataset showed that the faecal microbiome clustered separately from all the biopsy ones ( Figure 1B ). While the biopsies microbiomes did not cluster according to their sampling-location ( Figure 1B ), they did partially cluster based on subjects (Supplementary Figure 4A ). This shows that faecal and biopsy microbiomes significantly differ from each other, and that this difference is stronger than individual uniqueness. The PCoA plot of biopsies alone showed a clear clustering based on subjects ( Figure 1C ), but no clustering based on sampling-location (Supplementary Figure 4B ). This suggests that local microbiomes along the length of the large intestine mucosa have subtle differences, which are overcome by individual variability.
To better interpret these findings, we computed the number of shared MGSs between samples ( Figure 1 , D and E), and between subjects (Supplementary Figure 5 ). We observed a considerable MGS overlap between biopsy locations ( Figure 1D ), especially between TI/CA and TC (63%). On the other hand, Figure 1E shows that, whereas almost all the MGSs detected in biopsies were also detected in faeces (only one MGSs detected in TC, Acetobacter, was not detected in faeces), the strong separation between faeces and biopsies ( Figure 1B ) was due to the much higher faecal microbial richness. Within all the MGSs detected in any biopsy-microbiome, 30% were shared by at least two subjects, (Supplementary Figure 5 ), while this percentage, for the faecal microbiome, reaches 54% (Supplementary Figure 5 ). This indicates that individual variability is higher in biopsies than in faeces.
These results show that, although biodiversity was higher in faeces, since all the MGSs found in biopsies were detected in faeces as well, faecal sampling provides a good approximation of the average gut mucosa microbiota.
The biopsy-derived gut mucosal microbiomes offer a detailed insight into the biogeography of the large intestine. We next performed a taxonomic analysis of biopsies and faecal microbiomes, in order to assess which MGSs set the two groups apart, and which ones characterize specific biopsy locations. We first computed the total number of MGS-reads belonging to each phylum/class. Figure 2 shows all nine detected phyla ( Figure 2A ) and the top-ten classes ( Figure 2B ), sorted from the most to the least abundant in biopsies. Phylum Firmicutes was the dominant one, both in faeces and in biopsies, and it was mostly comprised of Clostridia. The phylum Bacteroidetes was the second most represented in biopsies (all belonging to class Bacteroides), whereas it was third in faeces after Actinobacteria (Supplementary Figure 6 ). These results are in agreement with current knowledge 5 .
We next compared the microbiome of all biopsies as a group to the faeces one. To this purpose, we plotted the 41 genera that were shared by these two groups ( Figure 2C ). The correlation between faeces and biopsies was low (R 2 =0.18) because of the genus Bacteroides, which was significantly enriched in biopsies only ( Figure 2C ). The removal of this genus from the shared genera resulted in a significantly higher correlation between biopsies and faeces (R 2 =0.44; Figure 2D ). Pearson's linear correlation of all shared 41 genera, including Bacteroides, between single biopsy locations, was extremely high (R>0.94; Figure 2 , E-G), whereas RE and faeces had a much lower correlation (R=0.42; Figure 2H ). While these results ( Figure 2 , E-H) agree with our previous observations, they also show that all the subjects equally contribute to all correlations. We can therefore conclude that the most relevant discrimination factor between faeces and biopsies is genus Bacteroides.
Intrigued by the high Bacteroides enrichment in all biopsy microbiomes, we looked at which
Bacteroides species were detected in each biopsy location. Known to be dominant in the gut microbiome 27 Figure 7) .
The most enriched genus in the faecal microbiota was the carbohydrate-fermenting genus Bifidobacterium (phylum Actinobacteria) ( Figure 2C) . B. adolescentis and B. longum were detected in the faecal samples of almost all subjects ( Supplementary Figure 8) . B. adolescentis, particularly, displayed an increasing gradient distribution along the large intestine, although its detection in biopsies was significantly lower than in faeces (Supplementary Figure 8 ).
Our results support our hypothesis that, with the exception of Bacteroides, faeces metagenomics provides a good approximation of the average mucosal microbiota. Faecal metagenomics, however, lacks the additional dimension provided by biopsies: a measure of the subtle changes MGSs undergo along the intestine. Since certain pathologies, such as Crohn's disease, are known to develop at specific locations along the intestine [28] [29] [30] , the ability to detect a pathological dysbiosis at such locations is likely to be fundamental for early diagnosis.
Antimicrobial resistance genes distribution along the large intestine. As the gut microbiota is a reservoir of antimicrobial resistance genes (ARGs) 31 , we next investigated how microbial communities along the intestine contribute to antibiotic resistance. We found that TI was less ARG-rich than both TC and RE, while faeces were significantly richer than any biopsy location ( Supplementary Figure 9 ). This indicates that TI microbiome may be more susceptible to antimicrobials than those from other locations.
We then looked at how the resistomes of this study correlate with one another ( Figure 3A , Supplementary Figure 10 , Supplementary Figure 11 ). The faecal resistome had a low correlation both with all biopsies grouped together (R=0.56) ( Figure 3A ) and with each single biopsy location ( Figure 3C ).
Biopsies' resistomes, on the other hand, had very high correlations with each other (R>0.85). These results show that biopsies, besides having very similar microbiota ( Supplementary Figure 11 ), had highly overlapping resistomes as well.
We next investigated the differentially enriched drug classes ( Figure 3B ) and resistance mechanisms ( Figure 3C ). The drug classes with the highest number of ARGs were cephamycin, tetracycline, fluoroquinolone, and glycopeptide antibiotics, particularly in TI and TC ( Figure 3B ). The mechanisms with the highest number of ARGs were Antibiotic efflux, Antibiotic inactivation, and Antibiotic target alteration ( Figure 3C ), with particular biopsy locations enrichments. Specifically, Antibiotic efflux and Antibiotic target alteration were more enriched in TI and RE, while Antibiotic inactivation was more enriched in TC. Interestingly, some mechanisms were exclusively represented in one location only, such as Antibiotic target replacement in RE, and Reduced permeability to antibiotic in TI.
Functional analysis by KEGG orthology, antiSMASH, and genome-scale metabolic models. To gain a deeper insight into the roles played by locally dominant species along the gut mucosa, we employed a set of functional analysis tools. We first measured how each sample was enriched in specific molecular functional orthologs by assigning KEGG orthologies 32 (https://www.genome.jp/kegg/ko.html) to genes detected at each biopsy location. Two KEGG orthology pathways were found to be significantly enriched Bacteroidetes vulgatus, Akkermansia muciniphila, Faecalibacterium prausnitzii, Parabacteroides distasonis, among others. As carotenoids have been shown to play a protective role in the human gut by regulating immunoglobulin A (IgA) production 33 , we speculate these microbes may play a role not only in carotenoid synthesis but also in regulating and preserving the gut immune system.
The antiSMASH database 34 was next employed to annotate the faecal and the biopsy-derived data, in order to find which secondary metabolites (SMs) are preferentially secreted by the microbes found in a specific sample-type. We found a significant enrichment of such metabolites in the faeces samples, compared to all the biopsy locations, due to the higher number of microbial species detected in faeces (Supplementary Figure 13A ). Within biopsies, TC was the most enriched location. Nine SMs were enriched in all biopsy locations, and an additional five were only detected in TC and RE (Supplementary Figure 13B ). Among these, we found anti-bacterial SMs resorcinol and bacteriocin (secreted by B. dorei, B. faecis, B. massiliensis, and B. cellulosilyticus, among others), and aryl polyene (secreted by Akkermansia muciniphila, and by most Bacteroides species), which provides bacteria with protection from oxidative stress similarly to carotenoids 35 .
We then employed genome-scale metabolic modelling (GEM) to investigate how locally-enriched microbes contribute to the metabolism of the gut microbiota and of the host. Specifically, we constructed and simulated GEMs of all the Bacteroides detected in biopsies, and of all the species that were most highly enriched at a single biopsy location, in at least two subjects (Supplementary Figure   14 ).
The Jaccard similarity analysis between the simulation results of all modelled species was in agreement with our former observations: there was no marked difference between biopsy locations ( Figure 4A ). However, several metabolites were especially, although not exclusively, produced/secreted at certain biopsy locations because of locally-enriched species (Figure 4 , B-C). In particular, we report a gradual shift from sugar to amino acid consuming microbes ( Figure 4B ). As expected 36 , acetate secretion (highest in TI) was greater than propionate's, which was greater than butyrate's (Supplementary Table   2 ). Formate and butyrate production was highest in RE ( Figure 4B) , where Ruminococcus lactaris, Eubacterium rectale, and B. nordii were enriched ( Figure 4C ), while propionate production was highest in TI ( Figure 4B ), which had higher concentrations of B. caccae, B. vulgatus, and B. fragilis ( Figure 4C ).
Our simulations yielded novel interesting insights into several metabolic pathways whose relevance to health or disease has already been assessed, but whose mechanisms are still largely obscure. In particular, we observed significantly enriched indole secretion and L-tryptophan (Trp) consumption in TI and TC ( Figure 4C xylanisolvens. Trp is an essential amino acid involved in several important functions, mostly connected with the host-microbiome interaction. As a fraction of Trp is known to be metabolised into indole by the gut microbiota 37 , our results show that this process mainly happens in TI and TC ( Figure 4C ).
Finally, by simulating the growth of the modelled species with varying oxygen concentrations, we observed different responses from locally dominant Bacteroides. In particular, B. vulgatus (dominant in TI) was shown to have a high oxygen-resistance ( Figure 4D ), whereas B. faecis (dominant in TC) showed a lower one ( Figure 4E ), and B. dorei (dominant in RE) was quite oxygen-sensitive ( Figure 4F ).
Discussion
The current best strategy to study gut mucosal microbial communities is to sample them through biopsies and to employ a shotgun sequencing technology to measure their microbial species composition. This study was designed to explore the advantages and limitations of using shotgun metagenomics and gut mucosal biopsy samples to quantify local microbiomes along the intestine of healthy subjects.
We show that faecal samples are richer in biodiversity. This is due, at least partially, to the expected lower number of reads mapping to microbial genes in biopsy-derived samples, as these contain higher amounts of human DNA. We also found important individual differences, particularly in the biopsy microbiota, less so in the faecal ones. Biodiversity was, therefore, the main discriminating factor between faeces and biopsies microbiota, followed by individual variability, while biopsy samplinglocation offered the least discriminating power across biopsies. Although not significantly different in composition, different gut locations vary in species concentrations: the same species may be found in most or all the biopsy locations, but with a different prevalence within each local community. Such variations are of crucial interest, as they may affect the host metabolism and homeostasis, or the onset and development of certain diseases where an altered composition of local communities is linked with such processes.
Despite the richer faecal biodiversity, faecal microbiota included almost all the MGSs found in mucosal biopsies. Additionally, faecal and biopsy microbiomes correlate with each other very well, with the exception of Bacteroides. This suggests that faeces metagenomics provides a good approximation of the average gut mucosal microbiota composition, in health.
Both faeces and biopsies were particularly rich in Firmicutes, a phylum known to be dominant in the gut microbiota 5 . Several microbial species belonging to genus Bacteroides were, however, significantly enriched in biopsies only, whereas species from genus Bifidobacterium were mainly enriched in faeces. Bacteroides are known as obligate anaerobic, bile-resistant bacteria, and one of the dominant genera in the gut 38 . Although they often behave as commensal organisms, some of their features allow them to turn into pathogens 38, 39 . They are among the rare prokaryotes provided with membrane sphingolipids, which are believed to enhance their ability to detect and cope with an unstable environment 40 . Furthermore, Bacteroides' outer membrane comprises lipopolysaccharides 41 ; although they usually trigger the host immune response, Bacteroides species-specific lipopolysaccharides structural differences prevent that 42 . Overall, Bacteroides are equipped with a unique interface with the host. Besides providing them with the capability to quickly detect and react to environmental changes, it also allows them to affect and modulate the host immune system 42 . Among the most enriched Bacteroides, we showed B. thetaiotaomicron and B. fragilis to gradually decrease from TI to RE, while B. faecis was significantly enriched in TC. Being among the best-studied Bacteroides, they are known as flexible foragers, capable of adapting to changes in microbial composition and glycan availability 43, 44 . Their enrichment may, therefore, have been caused by the depletion of other genera caused by bowel cleansing.
We next performed a set of functional analyses to investigate the roles played by locally dominant species. First, we explored the local enrichment of antibiotic resistance genes. The higher ARG-richness found in faeces was due to the greater MGS-richness of these samples. Interestingly, the number of resistance genes corresponding to several resistance mechanisms was higher in some biopsy locations, particularly TI and RE, than in faecal samples. In particular, although TI had the lowest gene/MGSrichness, and no unique MGSs of its own, it had the highest number of significantly changing ARGs. Some ARGs may exist as a result of acquired resistance to antibiotic use. We next performed a KEGG orthology analysis, which resulted in two pathways being significantly enriched. Of these, the first was carotenoid biosynthesis, which was enriched in TC because of the local prevalence of a few microbes, including Bacteroidetes vulgatus and Akkermansia muciniphila. The carotenoid biosynthesis pathway is responsible for producing beta-carotene, a precursor for retinol metabolism, and vitamin A. It has been shown that carotenoids play a protective role on the human gut by regulating IgA production 33 , and that retinol deficiency specifically affects Bacteroides vulgatus' growth in the gut 45 . Our data allows us to speculate that microbes possessing genes from this pathway, and locally enriched in TC, may play an important role in the retinol turnover of the gut, and in regulating IgA production.
GEM modelling was used to investigate the secretion/uptake of fermentation metabolites by the most enriched microbial species at each biopsy location. The simulations of our models provided new insights into partially known metabolic mechanisms involving microbial species which were found, in this work, to be dominant at specific locations only. We observed, for instance, a gradual shift, along the intestine, from sugar to amino acid consuming microbes, and we reported unprecedented oxygen-resistance details of specific Bacteroides species. Of particular interest was the discovery that Trp consumption and indole production were both significantly increased in TI and TC. Trp is an essential amino acid that plays fundamental roles in regulating nitrogen balance, gut immune system homeostasis, and serotonin production 46, 47 . A fraction of Trp is metabolised to indole and its derivatives by the gut microbiota, consistently with our simulation results 46 . Several diseases have been linked with reduced efficiency of this mechanism 47, 48 . In particular, inflammatory bowel disease has been associated with decreased serotonin production and Trp imbalance 49 . Bacteroides are among the few known microbes possessing Trp metabolism catalytic enzymes 47 . The main Bacteroides found in TI and TC that, according to our GEM simulation, were responsible for Trp consumption and indole secretion, were B. thetaiotaomicron, B. uniformis, B. vulgatus, B. faecis, and B. xylanisolvens. This novel information is extremely valuable, particularly as the impact of this mechanism is only starting to be uncovered in connection with a growing number of diseases. The Bacteroides species we report here in connection with Trp/indole metabolism will thus require further targeted investigation, as that could help prevent and treat such pathologies. As the results derived from our GEM simulation were obtained in silico,
further targeted experiments will be required in order to validate them.
One of the main limitations of this study was the small number of subjects that could be enrolled.
Very strict inclusion criteria were applied to ensure that all the included subjects were healthy, thus without any organic findings or gastrointestinal symptoms, which could have influenced the microbiota composition. Also, the sequencing depth of the biopsy-derived samples (0.15 million unique readcounts) was limited by the large number of human genes sampled together with the microbes. This is another unavoidable limitation of this method. The lower sequencing depth led to a partial measurement of the gut mucosal microbiota, which mainly emphasised the most abundant species.
While these are both important and expected limitations, we still chose to use this method with the aim of assessing what can be learnt from it. Biopsies can provide information that faeces cannot: subtle and otherwise undetectable variations in local microbiomes along the intestine that faeces cannot detect.
Such variations are of great interest since, as discussed, they can affect the onset and progression of serious pathologies. We thus believe these results, although still not optimal, provide new valuable insights into the mucosal gut microbiota. New methods will need to be devised to better isolate microbial species from human tissues, thus improving the sequencing depth. Also, given the promising results here described, larger cohorts now need to be investigated.
In conclusion, the current study showed that faecal samples provide a good approximation of the gut mucosal microbiome, although only metagenomics of gut mucosal biopsies can detect subtle variation in the local microbial communities' composition along the large intestine. Functional analysis of the biopsy metagenomics data was in agreement with the current knowledge while providing new fundamental information. Our GEM simulation, in particular, could detail which species are involved in only partially known metabolic mechanisms connected with health or disease. Our work provides the first detailed insight into which microbial species are associated with the gut mucosal microbiota of healthy individuals. Such valuable information will provide the starting point for more targeted future investigations on the gut microbiota.
Methods
Study population. Five healthy adult volunteers from Stockholm were selected from the participants to a study previously described 25 DNA extraction. Total genomic DNA was isolated from biopsy tissue or from 100-120 mg faecal sample using repeated bead beating, following a protocol previously described 50 Aligned reads were counted, normalized, and then downsized by R package MetaOMineR 26 . Downsizing, in particular, was performed in order to take into account the different sequencing depths across samples. Strain/species-level abundances of metagenomic species (MGS) -i.e., co-abundant genes with more than 100 genes originated from microbial species 53,54 -were profiled for each sample. Downsizing was performed for the whole biopsy-faeces dataset, then also for biopsy and faeces datasets separately.
MGS profiles were estimated as the mean abundance of the 50 genes of a given MGS (centroid of the clustered genes) and used to perform taxonomic investigations. Based on the orthologous genes from the KEGG database 55 , we annotated the quantified bacterial genes, and performed functional analysis of the genes detected in the biopsy dataset.
Statistical analysis. To assess if and how much each set of data (either sampling location-or patientspecific) differ, in the average, from the others, paired difference tests were performed. In particular, as the available data was not large and did not appear to be normally distributed, statistical assessments were performed with the Wilcoxon signed-rank test 56 proportioned by species abundances based on colon locations. We added an initial source of acetate and lactate on the basis of the average production profile of each microbe. For the second simulation, models were constrained both by the predicted biomass of the bacteria and by the diet. The flux balance analysis result (Supplementary Table 2 ) was used to find metabolite importance for each part of the colon. The sensitivity of the models to oxygen was simulated regarding the oxygen-uptake of the intestine (2 ml O 2 /min*100 grams tissue), where the micro-aerobic condition was considered as 5% O 2uptake. All references relative to the GEM method here described are available in Supplementary Materials.
Data availability. All raw metagenomic data have been deposited in the public EBI/NCBI Database under accession number PRJEB33194. 
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